ARA-290 is a synthetic peptide derived from erythropoietin (EPO), a hormone traditionally associated with red blood cell production.

The Ekosiisen Impact Project, an initiative under Asempa FM’s flagship current affairs programme Ekosiisen, has intensified its support for renal patients across Ghana, following a distress call from ...

The global erythropoietin drugs market was valued at approximately USD 6.87 billion in 2022 and is projected to grow at a healthy growth rate of around 1.5% during the forecast period from 2023 to ...

In contrast to the recently reported studies of Epo in patients hospitalized in intensive care units focusing on those with trauma, [60] our study was designed to minimize the risk of Epo-induced ...

Erythropoietin reduces infarct size, but it also carries some potentially adverse affects. How can you effectively administer this drug to improve the prognosis of heart disease patients?

Secondary erythrocytosis often results from conditions that cause tissue hypoxia or an improper increase in erythropoietin (EPO) production. EPO, the major regulator of erythropoiesis, has a comple ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Erythropoietin, aka EPO, is best known for its role in the Lance Armstrong cheating scandal. But EPO is also the star of another, darker tale.

The UCI has provisionally suspended three-time Polish U23 time trial champion Kacper Gieryk following a positive test for EPO during the 2024 World Championships in Zurich.

Objective To examine the feasibility of early and extended erythropoietin monotherapy after hypoxic ischaemic encephalopathy (HIE). Design Double-blind pilot randomised controlled trial. Setting Eight ...